Denis Chem Lab [DENISCHEM] vs Gujarat Themis [GUJTHEM] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Denis Chem Lab Ltd. wins in 12 metrics, Gujarat Themis Biosyn Ltd. wins in 7 metrics, with 0 ties. Denis Chem Lab Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Denis Chem Lab Ltd. | Gujarat Themis Biosyn Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 12.26 | 73.73 | Denis Chem Lab Ltd. |
| Price-to-Book Ratio | 1.22 | 13.36 | Denis Chem Lab Ltd. |
| Debt-to-Equity Ratio | 0.09 | 27.04 | Denis Chem Lab Ltd. |
| PEG Ratio | 0.14 | -17.55 | Denis Chem Lab Ltd. |
| EV/EBITDA | 5.61 | 52.76 | Denis Chem Lab Ltd. |
| Profit Margin (TTM) | 43.34% | 29.99% | Denis Chem Lab Ltd. |
| Operating Margin (TTM) | 6.45% | 40.16% | Gujarat Themis Biosyn Ltd. |
| EBITDA Margin (TTM) | 6.45% | 40.16% | Gujarat Themis Biosyn Ltd. |
| Return on Equity | 9.49% | 19.64% | Gujarat Themis Biosyn Ltd. |
| Return on Assets (TTM) | 7.19% | 16.19% | Gujarat Themis Biosyn Ltd. |
| Free Cash Flow (TTM) | $44.64M | $-251.22M | Denis Chem Lab Ltd. |
| Dividend Yield | 4.03% | 0.17% | Denis Chem Lab Ltd. |
| 1-Year Return | -29.77% | 31.69% | Gujarat Themis Biosyn Ltd. |
| Price-to-Sales Ratio (TTM) | 0.62 | 22.23 | Denis Chem Lab Ltd. |
| Enterprise Value | $1.07B | $36.09B | Gujarat Themis Biosyn Ltd. |
| EV/Revenue Ratio | 0.62 | 22.65 | Denis Chem Lab Ltd. |
| Gross Profit Margin (TTM) | 49.30% | 83.29% | Gujarat Themis Biosyn Ltd. |
| Revenue per Share (TTM) | $125 | $15 | Denis Chem Lab Ltd. |
| Earnings per Share (Diluted) | $6.28 | $4.40 | Denis Chem Lab Ltd. |
| Beta (Stock Volatility) | N/A | -0.17 | N/A |
Denis Chem Lab Ltd. vs Gujarat Themis Biosyn Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Denis Chem Lab Ltd. | 1.96% | -4.77% | -9.16% | -6.26% | -17.73% | -12.08% |
| Gujarat Themis Biosyn Ltd. | 2.45% | -7.03% | 7.92% | 39.85% | 0.71% | -8.80% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Denis Chem Lab Ltd. | -29.77% | -5.54% | 9.45% | -14.17% | 216.15% | 216.15% |
| Gujarat Themis Biosyn Ltd. | 31.69% | 84.69% | 84.69% | 84.69% | 84.69% | 84.69% |
Performance & Financial Health Analysis: Denis Chem Lab Ltd. vs Gujarat Themis Biosyn Ltd.
| Metric | DENISCHEM | GUJTHEM |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.07B | ₹35.41B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 4,744 | 79,452 |
| 90 Day Avg. Volume | 9,989 | 106,446 |
| Last Close | ₹71.32 | ₹411.65 |
| 52 Week Range | ₹56.10 - ₹109.25 | ₹225.05 - ₹479.00 |
| % from 52W High | -34.72% | -14.06% |
| All-Time High | ₹232.90 (Jun 17, 2024) | ₹479.00 (Oct 27, 2025) |
| % from All-Time High | -69.38% | -14.06% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.01% | 0.10% |
| Quarterly Earnings Growth | 0.06% | -0.04% |
| Financial Health | ||
| Profit Margin (TTM) | 0.43% | 0.30% |
| Operating Margin (TTM) | 0.06% | 0.40% |
| Return on Equity (TTM) | 0.09% | 0.20% |
| Debt to Equity (MRQ) | 0.09 | 27.04 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹63.14 | ₹24.29 |
| Cash per Share (MRQ) | N/A | ₹0.92 |
| Operating Cash Flow (TTM) | ₹105.01M | ₹970.68M |
| Levered Free Cash Flow (TTM) | ₹80.76M | ₹487.72M |
| Dividends | ||
| Last 12-Month Dividend Yield | 4.03% | 0.17% |
| Last 12-Month Dividend | ₹4.00 | ₹0.67 |
Valuation & Enterprise Metrics Analysis: Denis Chem Lab Ltd. vs Gujarat Themis Biosyn Ltd.
| Metric | DENISCHEM (Apr 26, 2026) | GUJTHEM (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 12.26 | 73.73 |
| Forward P/E | N/A | N/A |
| PEG Ratio | 0.14 | -17.55 |
| Price to Sales (TTM) | 0.62 | 22.23 |
| Price to Book (MRQ) | 1.22 | 13.36 |
| Market Capitalization | ||
| Market Capitalization | ₹1.07B | ₹35.41B |
| Enterprise Value | ₹1.07B | ₹36.09B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.62 | 22.65 |
| Enterprise to EBITDA | 5.61 | 52.76 |
| Risk & Other Metrics | ||
| Beta | N/A | -0.17 |
| Book Value per Share (MRQ) | ₹63.14 | ₹24.29 |
Financial Statements Comparison: Denis Chem Lab Ltd. vs Gujarat Themis Biosyn Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | DENISCHEM (2025) | GUJTHEM (2025) |
|---|---|---|
| Revenue/Sales | 1.73B | 1.51B |
| Cost of Goods Sold | 981.93M | 318.78M |
| COGS % of Revenue | 56.7% | 21.1% |
| Gross Profit | 751.05M | 1.19B |
| Gross Margin | 43.3% | 78.9% |
| Research & Development | N/A | 34.37M |
| Operating Income (EBIT) | 103.13M | 642.49M |
| Operating Margin | 6.0% | 42.6% |
| EBITDA | 190.23M | 713.04M |
| EBITDA Margin | 11.0% | 47.3% |
| Pre-Tax Income | 111.11M | 655.38M |
| Pre-Tax Income % of Revenue | 6.4% | 43.5% |
| Income Tax | 30.36M | 167.66M |
| Income Tax % of Revenue | 1.8% | 11.1% |
| Net Income (Profit) | 80.76M | 487.72M |
| Profit Margin | 4.7% | 32.3% |
Balance Sheet & Liquidity Metrics
| Metric | DENISCHEM (2025) | GUJTHEM (2025) |
|---|---|---|
| Cash & Equivalents | 8.50M | 116.94M |
| Total Current Assets | 706.45M | 519.73M |
| Total Current Assets % of Revenue | 40.8% | 34.5% |
| Total Current Liabilities | 261.73M | 205.60M |
| Total Current Liabilities % of Revenue | 15.1% | 13.6% |
| Long-Term Debt | 4.53M | 296.36M |
| Long-Term Debt % of Revenue | 0.3% | 19.7% |
| Total Shareholders Equity | 851.04M | 2.48B |
| Retained Earnings | 390.31M | 2.37B |
| Retained Earnings % of Revenue | 22.5% | 157.4% |
| Property, Plant & Equipment | 39.91M | 411.30M |
Cash Flow Statement Comparison
| Metric | DENISCHEM (2025) | GUJTHEM (2025) |
|---|---|---|
| Operating Cash Flow | 105.01M | 970.68M |
| Operating Cash Flow % of Revenue | 6.1% | 64.4% |
| Capital Expenditures | N/A | -1.16B |
| Free Cash Flow | 44.64M | -251.22M |
| FCF Margin | 2.6% | -16.7% |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | DENISCHEM | GUJTHEM |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 13.88M | 108.97M |
| Float Shares | N/A | 29.52M |
| % Held by Insiders | 78.40% | 71.98% |
| % Held by Institutions | 0.00% | 1.18% |
| % Held by Public | 21.60% | 26.84% |
Dividend Analysis & Yield Comparison: Denis Chem Lab Ltd. vs Gujarat Themis Biosyn Ltd.
| Metric | DENISCHEM | GUJTHEM |
|---|---|---|
| Last 12-Month Dividend | ₹4.00 | ₹0.67 |
| Last 12-Month Dividend Yield | 4.03% | 0.17% |
| 3-Year Avg Annual Dividend | ₹3.67 | ₹0.22 |
| 3-Year Avg Dividend Yield | 1.73% | 0.17% |
| 3-Year Total Dividends | ₹11.00 | ₹0.67 |
| Ex-Dividend Date | Sep 19, 2025 | Sep 04, 2025 |